Troponin News and Research

RSS

Sphingotec's penKid is a reliable marker for detection and monitoring of acute kidney injury

Diagnostics company SphingoTec GmbH today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC Emergency Medicine.

21 Dec 2019

Heavy drinking damages the heart

Drinking too much destroys the liver, as is well known. A new study published in the Journal of the American Heart Association on December 18, 2019, shows that excessive alcohol consumption also damages the heart muscle. This is seen by a rise in the level of certain biological molecules in the blood.

18 Dec 2019

Harmful alcohol consumption pattern may damage heart tissue

A pattern of harmful alcohol consumption, or heavy drinking, increases level of blood biomarkers indicating heart tissue damage, according to new research published today in the Journal of the American Heart Association, the open access journal of the American Heart Association.

18 Dec 2019

Reducing STAT demand can improve patient care, suggests new study

While a lab test might be ordered STAT to help save a life, a new study suggests that the STAT test order should rest in peace, and instead the time standard for most clinical lab tests, like the commonly requested complete blood count, or CBC, should be more efficient.

3 Dec 2019

New blood test for protein biomarkers could identify people in need of treatment

Without occasionally looking under the hood, it's difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren't currently in treatment.

11 Nov 2019

Myocardial infarction model developed using cardiomyocytes

Researchers at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences developed a model of myocardial infarction using cardiomyocytes differentiated from human induced pluripotent stem cells.

7 Nov 2019

Chronic kidney disease associated with increased risk of adverse cardiovascular outcomes

Chronic kidney disease, which afflicts an estimated 6.4% of U.S. adults 45 and older, is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new research from Mayo Clinic.

23 Oct 2019

Women receive poorer heart attack treatment than men

Women receive poorer heart attack treatment than men, even when rates of diagnosis are the same, according to new research funded by the British Heart Foundation (BHF) and published in the Journal of the American College of Cardiology.

15 Oct 2019

New cardio trial shows reduced wait times and hospital admissions

A major new study led by Flinders University Professor Derek Chew shows that up to 70% of patients presenting to Australian hospital emergency departments with chest pain could be safely discharged in less time than they currently are under standard Australian protocols.

4 Sep 2019

Rapid diagnosis protocol does not improve outcomes for patients with chest pain

Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T (hs-cTnT) protocol is safe, according to late breaking results from the RAPID-TnT trial presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation.

4 Sep 2019

What you eat affects your heart more than your diet regimen

The results of the OmniHeart trial are in and the clear winner is … HEALTHY FOOD! Indeed, the conclusion of the trial may have come as a bit of an anticlimax to those diehards who swear by one diet or the other, but the results are unambiguous.

28 Aug 2019

Women experience the same key heart attack symptoms as men

Women who have heart attacks experience the same key symptoms as men, quashing one of the reasons given for women receiving unequal care.

21 Aug 2019

High troponin levels after exercise predict risk of cardiovascular events

Regular exercise is healthy and reduces the risk of cardiovascular disease. Nevertheless, it appears that prolonged and/or intensive exercise can lead to an increase in cardiac biomarkers in the blood, such as the regulatory protein troponin. Troponin is a protein that is present in every heart muscle cell.

14 Aug 2019

RNA-binding protein SRSF3 appears to be key factor for proper heart contraction, survival

A team of scientists led by Dr Enrique Lara Pezzi at the Centro Nacional de Investigaciones Cardiovasculares has identified the RNA-binding protein SRSF3 as an essential factor for proper heart contraction and survival.

9 Jul 2019

Advanced testing does not help predict major cardiac events, research shows

Most patients seen in a hospital emergency department for chest pain did not experience major cardiac events within six months following discharge, new research from UC Davis Health and Oregon Health Sciences University cardiologists shows.

29 May 2019

Blood proteins may be useful for predicting risk of developing heart failure

Cardiovascular disease remains the leading cause of pain, suffering and death in the United States, and despite tremendous advances in knowledge on prevention, treatment of risk factors such as cholesterol, blood pressure and obesity is not optimal.

21 May 2019

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

Full marathons may increase concentrations of biomarkers of cardiac strain

Full marathons may significantly raise concentrations of several biomarkers of strain on the heart, according to new research in Circulation, Journal of the American Heart Association.

3 Dec 2018

Drug therapy can improve outcomes for acutely ill heart patients

A drug therapy used for patients with chronic heart failure also improves markers of poor prognosis in individuals who are hospitalized with acute heart failure, new Yale-led research shows.

12 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018